Today's Clinical Lab: Virtual Staining Could Change How We Use Limited Tissue in Pathology

In a November 2026 article for Today's Clinical Lab, our Chief Scientific Officer, Christopher Jackson, MD, MEng, explores how AI-powered virtual biomarker staining could help address one of pathology's longstanding challenges: making the most of limited tissue samples.

Dr. Jackson explains how the technology's potential goes beyond tissue preservation. It could fundamentally change how pathologists approach diagnostic testing, enabling more comprehensive evaluations while reducing some of the practical limitations of traditional immunohistochemical (IHC).

Read Christopher's perspective in Today's Clinical Lab:

Next
Next

ViewsML to Address Biobank Access and AI Readiness at ISBER’s International Biospecimen Summit